Factors connected with efficacy of single ketamine infusion in bipolar depression

Journal Title: Psychiatria Polska - Year 2014, Vol 48, Issue 1

Abstract

Aim. The aim of this study was to evaluate the efficacy of single ketamine infusion and clinical and biochemical factors connected with such efficacy, in patients with bipolar depression, which had not improved on antidepressant treatment. Methods. The study included 42 patients (32 women, 10 men), aged 22-67 years, with bipolar depression. They received .1 mood-stabilizing medications of first and/or second generation. After discontinuation of antidepressants (.7 days), intravenous infusion of ketamine (0.5mg/kg body weight) was performed. The assessment of depression by the 17-item Hamilton Depression Rating Scale was made before, and after 1, 3, 7 and 14 days following administration of ketamine. The assumed criterion for clinical improvement was the reduction of .50% score on the Hamilton scale after 7 days. In a subgroup of 20 patients, prior to administration of ketamine, serum concentrations of homocysteine, vitamin B12, folic acid, neurotrophins and inflammatory proteins were measured. Results. In the whole group, the severity of depression on the Hamilton scale decreased significantly 24 hours after administration of ketamine from 22.6±5.1 to 15.6±7.4 points. After 7 days it was 13±7 and after 14 days - 11.8±7.8 points. Patients showing clinical improvement (n=22) had significantly higher frequency of alcohol addiction and family history of alcoholism. Biochemical tests in the subset of 20 patients demonstrated that those with clinical improvement (n=10) had higher serum concentrations of vitamin B12 and receptor-1 Vascular Endothelial Growth Factor before administration of ketamine. Ketamine infusion was well tolerated. Conclusions. The results confirm a rapid antidepressant effect of ketamine infusion maintaining for 2 weeks, in a considerable proportion of patients with bipolar depression, and good clinical tolerance of such procedure. Also, some clinical and biochemical factors associated with ketamine efficacy were shown.

Authors and Affiliations

Agnieszka Permoda-Osip, Maria Skibińska, Alicja Bartkowska-Śniatkowska, Sebastian Kliwicki, Janusz Rybakowski

Keywords

Related Articles

Depresja u chorych z padaczką

Depresja jest jednym z najczęstszych zaburzeń psychicznych towarzyszących padaczce. Za przyczynę występowania depresji u pacjentów z padaczką uważa się: zmiany neurochemiczne i neurofizjologiczne, zachodzące w strukturac...

Neuroanatomical, genetic and neurochemical aspects of infantile autism

Infantile autism is a neurodevelopmental disorder characterized by impairments in communication, reciprocal social interaction and restricted repetitive behaviors or interests. Although the cause of these disorders is no...

Research on the role of life events in bipolar disorder

This review focuses on latest research regarding the role of life events in bipolar disorder. Description of important patients experiences and mechanisms, according to which they operate, is the key issue in diagnostics...

Genetyka i farmakogenetyka zaburzeń nastroju

Lekarze patrzą na badania genetyczne w psychiatrii zarówno z nadzieją, jak i z ciekawością, czasem z domieszką rozczarowania. Istotnie, w ciągu ostatnich 30 lat wiele wyników badań nie zostało potwierdzonych a zastosowań...

Download PDF file
  • EP ID EP110806
  • DOI -
  • Views 97
  • Downloads 0

How To Cite

Agnieszka Permoda-Osip, Maria Skibińska, Alicja Bartkowska-Śniatkowska, Sebastian Kliwicki, Janusz Rybakowski (2014). Factors connected with efficacy of single ketamine infusion in bipolar depression. Psychiatria Polska, 48(1), 35-47. https://europub.co.uk/articles/-A-110806